Press release

Federal judge grants injunction enabling American Kidney Fund to continue helping low-income Californians with kidney failure

ROCKVILLE, Md. (December 30, 2019) – The following statement may be attributed to LaVarne A. Burton, president and chief executive officer of the American Kidney Fund (AKF):

"Today, the American Kidney Fund (AKF) joins 3,700 low-income Californians living with kidney failure in applauding the decision by Judge David Carter in the U.S. District Court for the Central District of California to grant an emergency injunction preventing AB 290 from becoming law. This is important news for patients with kidney failure who depend upon AKF to ensure access to the health care that they must have to survive.

"Because this injunction prevents AB 290 from becoming law, pending the outcome of a trial, AKF can continue to serve California's low-income dialysis and transplant patients who depend on AKF for charitable premium assistance. We will also immediately re-open the program to new grant applicants who qualify for assistance.  We are grateful that Judge Carter recognized the immediate and irreparable harm to patients if AKF could not continue to assist them with health insurance premium payments. We are communicating with our grant recipients so they remain fully informed throughout this process."

About the AKF charitable assistance program: For more than 20 years, the American Kidney Fund's 100% needs-based Health Insurance Premium Program (HIPP) has provided grants to low-income dialysis and kidney transplant patients, helping them pay for their health coverage when they cannot afford to do so on their own. AKF's program is governed by Advisory Opinion 97-1, which was issued by the Inspector General of the U.S. Department of Health and Human Services in 1997. AO 97-1 requires strict firewalls and safeguards to protect and ensure patient choice of provider and insurance coverage, providing a safe harbor from federal beneficiary inducement laws. This protocol has set the standard for dozens of similar national charity care programs for more than two decades.

For more information on the lawsuit and media inquiries, please contact: akfpress@actumllc.com

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nonprofit with the greatest direct impact on people with kidney disease. AKF works on behalf of 1 in 7 Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. AKF fights for kidney health for all through programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator for 21 consecutive years and the Platinum Seal of Transparency from Candid, formerly known as GuideStar. 

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.